10:52 AM EST, 02/04/2025 (MT Newswires) -- Movano (MOVE) said Tuesday it has begun a clinical trial with its new cuffless blood pressure wrist wearable.

The company said in the study, the device will be used to monitor pulse pressure waveforms compared with a hospital grade blood pressure device and will also collect data on pulse rate, blood oxygen saturation and other vital signs.

The trial is expected to include at least 70 participants and be finished in the second week of February, Movano said.

The company said the study follows three clinical trials where it used its non-invasive devices to collect pulse pressure waveform data from more than 60 participants.

Price: 5.43, Change: +0.03, Percent Change: +0.56